• France to impose quarantine on UK travellers
• Adults aged 30 and over offered vaccine in England
• Antibodies in 75% of UK adult population
• Slovakia approves Sputnik V use
• AZ & Nipro Corp sign vaccine supply agreement for Japan
• France will impose a compulsory quarantine on travellers arriving from the UK due to concerns over the spread of the Indian variant.
• Serbia and Slovenia have agreed to mutually recognise each other’s vaccination certificates. The deal covers vaccines yet to be approved by the EMA including Sinopharm and Sputnik V.
• Germany’s seven-day incidence rate has fallen below 50 cases per 100,000 people for the first time since October last year.
• People aged 30 and 31 in England are being invited to book to have their first dose of a vaccine.
• In the UK approximately 75% of adults have antibodies; 76% of adults in England, 77% in Wales, 75% in Northern Ireland while it is slightly lower in Scotland at 69%.
• The United Arab Emirates said vaccinations will be mandatory for people attending all “live events” from 6 June. The policy applies to all sports, cultural, social, arts exhibition, activities and events.
• AstraZeneca and Nipro Corp have signed an agreement to supply the company’s vaccine in Japan.
• The Maldives is to restrict movement of residents. Citizens will be allowed out for a few hours each day for essential supplies and a strict curfew will be in place from 4pm to 8am the next day.
• The European Medicines Agency will announce on Friday whether it has approved the Pfizer/BioNTech vaccine for 12- to 15-year-olds.
• Bahrain is to close shopping malls, restaurants and coffee shops for two weeks starting from tomorrow. Beauty salons, spas and barber shops will also close and no event or conference should be held during this period.
• The Construction Leadership Council has warned that cement, some electrical components, timber, steel and paints are all in short supply. It blamed unprecedented levels of demand that are set to continue.
• Slovakia has become the second EU country to authorise the use of the Russian-made Sputnik V vaccine.